Search clinical trials for: PG-760564

Total 66 results

Procter and Gamble

Completed

Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days

Healthy

United States
Procter and Gamble

Completed

Study to Evaluate Potential Food Effects

Healthy

United States
Procter and Gamble

Completed

Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate

Rheumatoid Arthritis

United States, Hungary, Czech Republic, Netherlands, Poland, United Kingdom
Procter and Gamble

Completed

Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis

Osteoarthritis, Knee

Hungary, United Kingdom
Procter and Gamble

Completed

Study of Oral PG-116800 Following a Heart Attack

Myocardial Infarction | Heart Failure | Heart Enlargement

United States, Canada, Poland
Progen Pharmaceuticals

Completed

Study of CGC-11047 (PG-11047) in Subjects With Advanced Refractory Solid Tumors

Cancer

United States
University of Padova

Completed

Digital Therapy in Shoulder Rehabilitation.

Shoulder Pain

Italy
Boston Scientific Corporation

Completed

ELEVATE (Evaluation of Left Ventricular Autothreshold) 3.0 (ELEVATE 3)

Heart Failure

United States
Medicines for Malaria Venture
Richmond Pharmacology Limited

Completed

Determine the Tolerability and Safety of Atovaquone-proguanil (ATV-PG) Co-administered With Amodiaquine (AQ)

Malaria

United Kingdom
Assistance Publique Hopitaux De Marseille

Not yet recruiting

PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia (PROMISE)

Patients With Schizophrenia
Glycemic Index Laboratories, Inc
Canadian Center for Functional Medicine; InovoBiologic Inc.

Completed

Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia

Blood Glucose, Postprandial

Canada
ProGen. Co., Ltd.

Recruiting

A Study to Assess Safety, Pharmacokinetics and Pharmacodynamics of PG-102(MG12) in Healthy Volunteers

Healthy | Overweight

Korea, Republic of
Muğla Sıtkı Koçman University

Completed

Anti-inflammatory Markers in Endometrioma

Inflammation | Endometrioma

Turkey
Hiroshima Kyoritsu Hospital

Completed

The Effect of Semi-solid Feeding After Percutaneous Endoscopic Gastrostomy (PEG) on the Incidence of Aspiration Pneumonia and Postoperative Length of Stay

Aspiration Pneumonia | Gastrostomy
Amanda Harrist

Completed

Families and Schools for Health (FiSH)

Overweight | Pediatric Obesity
Novindiet Clinic
Tehran University of Medical Sciences; University of Nottingham

Completed

Effects of Almond Versus Pistachio on Weight Loss

Obesity | Overweight

Iran, Islamic Republic of
Boehringer Ingelheim

Withdrawn

BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)

Lupus Erythematosus, Systemic
Boehringer Ingelheim

Withdrawn

This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated

Healthy
Universidad Simón Bolívar

Completed

Paragastric Autonomic Neural Blockade as Part of Combined Anesthesia.

Anesthesia Morbidity | Opioid Use

Colombia
Université Libre de Bruxelles

Completed

Comparison of Electronic Cigarettes and Tobacco Cigarettes on Cardiovascular Function and Oxidative Stress

Cardiovascular Risk Factor

Belgium
Beth Israel Medical Center

Completed

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Immune Thrombocytopenia | Myelodysplasia | Chemotherapy Induced Thrombocytopenia | Aplastic Anaemia

United States
Boehringer Ingelheim

Completed

A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors)

Solid Tumors

Japan
Boehringer Ingelheim

Recruiting

A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Melanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)

Netherlands
Boehringer Ingelheim

Completed

HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia (HORNBILL)

Diabetic Retinopathy

United States, United Kingdom
Boehringer Ingelheim

Completed

Safety and Pharmacokinetics of Single Rising Doses of BI 705564 and Food Effect on BI 705564 in Healthy Male Subjects

Healthy

Germany
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients

Memory Disorders | Delirium, Dementia, Amnestic, Cognitive Disorders

Netherlands
Ain Shams University

Unknown

PGI2 Versus Nitroglycerine for Management of Pulmonary Hypertension After Valve Surgeries

Pulmonary Hypertension

Egypt
University of Miami
James and Esther King Biomedical Research Program

Terminated

Evaluation of Acute and Subacute Effects of Nicotine Free Electronic Cigarette(NCFE) Vapors

Healthy Lifetime Non-smokers

United States
OSE Immunotherapeutics
Boehringer Ingelheim

Active, not recruiting

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

Solid Tumor, Adult

France, Belgium
Uludag University

Not yet recruiting

Rhomboid Intercostal and Subserratus / Paravertebral Block

Analgesia | Anesthesia | Thoracic

Turkey
Jules Bordet Institute
Merck KGaA, Darmstadt, Germany

Active, not recruiting

Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial) (AURA)

Non-metastatic Muscle Invasive Bladder Cancer

France, Belgium
Boehringer Ingelheim

Not yet recruiting

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Diabetic Retinopathy
University of Virginia

Completed

The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants

Patent Ductus Arteriosus | Indomethacin Therapy
Universitaire Ziekenhuizen KU Leuven

Completed

Suture Materials: an Evaluation

Suture Materials
Nantes University Hospital
Paion UK Ltd.

Completed

REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19: REHSCU Study (REHSCU)

Stroke | COVID-19 | Sepsis | Shock | Trauma | Acute Respiratory Failure

France
Université du Québec à Trois-Rivières

Completed

Integrative Couple Treatment for Pathological Gambling (ICT-PG)

Pathological Gambling

Canada
University Hospital, Antwerp

Active, not recruiting

Nasal Airway Stent (Nastent®) Study in OSA (Nastent)

Obstructive Sleep Apnea

Belgium
Ono Pharma USA Inc
Ono Pharmaceutical Co. Ltd

Completed

An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment

Healthy | Hepatic Impairment

United States
University of California, Berkeley
Alcon Research

Completed

Artificial Tears, Tear Lipids and Tear Film Dynamics (AlconAT)

Dry Eye

United States
Heart and Diabetes Center North-Rhine Westfalia

Completed

Leg Fluid Shift in Patients With Chronic Heart Failure and Obstructive or Central Sleep Apnea

Obstructive Sleep Apnoea | Cheyne Stokes Respiration | Central Sleep Apnoea

Germany
Biotest Pharmaceuticals Corporation
Biotest

Completed

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

Multiple Myeloma

United States
Boehringer Ingelheim

Terminated

A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery

Colorectal Cancer

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

In-vivo Effects of E-cigarette Aerosol on Innate Lung Host Defense (Cinimic)

Smoking | Healthy

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Recurrent Ovarian Carcinoma | Primary Peritoneal Carcinoma

United States
Lorillard Tobacco Company

Completed

Characterization of Nicotine Exposure and Urge-to-Smoke Following Use of Electronic and Conventional Cigarettes

Smoking

United States
Blymum Srl

Completed

Occult Obscure Gastrointestinal Bleeding (OGIB)

Gastrointestinal Bleeding

Italy
Organon and Co

Completed

The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)

Osteoarthritis Pain
Eli Lilly and Company

Completed

A Study of LY2484595 in Healthy Subjects

Healthy Volunteers

United States
Boehringer Ingelheim

Recruiting

A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer

Head and Neck Squamous Cell Carcinoma (HNSCC)

United States, Spain, Thailand, United Kingdom, France, Malaysia, Mexico, Moldova, Republic of, Romania, Poland, Japan
Paion UK Ltd.
Premier Research Group plc

Completed

Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy

Sedation

United States

3

Subscribe